A Threat of the Klebsiella Pneumoniae Carbapenemase-Producing Strains Among Transplant RecipientsMLYNARCZYK, G; KOSYKOWSKA, E; CHMURA, A et al.Transplantation proceedings. 2011, Vol 43, Num 8, pp 3135-3136, issn 0041-1345, 2 p.Conference Paper

Bisphosphonates are effective prophylactic of early bone loss after renal transplantationNOWACKA-CIECIURA, E; CIECIURA, T; BACZKOWSKA, T et al.Transplantation proceedings. 2006, Vol 38, Num 1, pp 165-167, issn 0041-1345, 3 p.Conference Paper

Strains of Klebsiella pneumoniae Producing Extended Spectrum Beta-Lactamases, Isolated from Organ RecipientsWALTER DE WALTHOFFEN, S; MLYNARCZYK, A; SAWICKA-GRZELAK, A et al.Transplantation proceedings. 2011, Vol 43, Num 8, pp 3128-3129, issn 0041-1345, 2 p.Conference Paper

The Dominant Sequence Types of Vancomycin-Resistant Enterococcus faecium Among Transplantation Ward PatientsMLYNARCZYK, A; SZYMANEK-MAJCHRZAK, K; CISZEK, M et al.Transplantation proceedings. 2011, Vol 43, Num 8, pp 3132-3134, issn 0041-1345, 3 p.Conference Paper

Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus treated with sandimmune and sandimmune neoralSERAFINOWICZ, A; GACIONG, Z; BACZKOWSKA, T et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3140-3141, issn 0041-1345Conference Paper

Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with sandimmun-neoralSERAFINOWICZ, A; GACIONG, Z; BACZKOWSKA, T et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3138-3139, issn 0041-1345Conference Paper

IgA nephropathy in kidney allograft recipients-therapeutic perspectivePAZIK, J; BACZKOWSKA, T; LEWANDOWSKI, Z et al.Transplantation proceedings. 2006, Vol 38, Num 1, pp 112-114, issn 0041-1345, 3 p.Conference Paper

Elevated serum immunoglobulins after steroid withdrawal in renal allograft recipientsNOWACKA-CIECIURA, E; DURLIK, M; CIECIURA, T et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 564-566, issn 0041-1345Conference Paper

Homocysteine and lipid peroxidation products : Important atherosclerosis risk factors in renal allograft recipients?SERAFINOWICZ, A; KUKUŁA, K; DURLIK, M et al.Transplantation proceedings. 2000, Vol 32, Num 6, pp 1367-1368, issn 0041-1345Conference Paper

Influence of angiotensin-converting enzyme inhibitor treatment of the carotid artery intima-media complex in renal allograft recipientsCIECIURA, T; SENATORSKI, G; RELL, K et al.Transplantation proceedings. 2000, Vol 32, Num 6, pp 1335-1336, issn 0041-1345Conference Paper

Optimal Mycophenolic Acid and Mycophenolic Acid Glucuronide Levels at the Early Period After Kidney Transplantation Are the Key Contributors to Improving Long-Term OutcomesBACZKOWSKA, T; SADOWSKA, A; DURLIK, M et al.Transplantation proceedings. 2009, Vol 41, Num 8, pp 3019-3023, issn 0041-1345, 5 p.Conference Paper

Pneumonia in kidney allograft recipientsPAZIK, J; DURLIK, M; LEWANDOWSKA, D et al.Transplantation proceedings. 2003, Vol 35, Num 6, pp 2202-2204, issn 0041-1345, 3 p.Conference Paper

The role of the protocol biopsies in renal allograft recipientsBACZKOWSKA, T; PERKOWSKA-FRANCKA, A; GALAZKA, Z et al.Transplantation proceedings. 2003, Vol 35, Num 6, pp 2179-2181, issn 0041-1345, 3 p.Conference Paper

Cyclosporine blood concentration at 2 hours (C₂) from drug ingestion as the best single indicator of adequate cyclosporine immunosuppression in renal allograft recipients: A four-year follow-upBACZKOWSKA, T; SERAFINOWICZ, A; LAO, M et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 556-557, issn 0041-1345Conference Paper

Use of daclizumab in the immunosuppression of high-risk kidney and kidney/pancreas recipients: Warsaw transplantation center experienceBACZKOWSKA, T; KUKULA, K; LAO, M et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 551-552, issn 0041-1345Conference Paper